Massive claims study aims to validate Real-World evidence for heart failure drugs
NCT ID NCT07599293
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This study uses healthcare claims data from nearly 40,000 people to see if the results of a major clinical trial (EMPEROR-Preserved) can be reproduced in a real-world setting. Researchers are comparing two diabetes drugs, empagliflozin and sitagliptin, in patients with heart failure with preserved ejection fraction and type 2 diabetes. The goal is to learn when real-world data can be trusted to answer clinical questions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Empagliflozin and sitagliptin
- What this could lead to
- If successful, this could show that analyzing real-world data can reliably replace or supplement traditional clinical trials for certain questions.
- What could go wrong
- This is an observational study, not a controlled experiment, so results may be biased or not match the original trial. It cannot prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a blood flow 'Tourniquet' workout repair diabetic nerve damage?
- Could a common diabetes drug weaken your bones?
- Can shedding pounds reboot the Heart's exercise engine?
- Can a spice and a mindset shift ease diabetic nerve pain?
- Ancient wisdom meets modern care: could chinese medicine boost diabetes Self-Management?
- Could a peptide injection help rebuild Insulin-Making cells?